Shiying Yu

发表

Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials

Yanxia Shi, Y. Ling, Lin Wang, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.